Call for Papers: Special Issue on Advances in Cancer Research. Submit your manuscript by End of May.
Invitation for Contributions: International Conference on Public Health. Abstract submission deadline extended to 15th June.
Submit Your Research: Journal of Fatima Jinnah Medical University welcomes submissions on emerging topics in healthcare. Deadline: 15th May
“Comparison of Octreotide and Terlipressin Efficacy in Prevention of Early Variceal Rebleed after Endoscopic Variceal Band Ligation’’

“Comparison of Octreotide and Terlipressin Efficacy in Prevention of Early Variceal Rebleed after Endoscopic Variceal Band Ligation’’

Authors

  • MUHAMMAD KASHIF, MUHAMMAD KHURRAM SALEEM ABBAS RAZA, ARIF MAHMOOD SIDDIQUI

Abstract

Objectives: Terlipressin and octreotide are both used as adjuvant therapy to endoscopic variceal band ligation however data is scarce on the head-to-head efficacy of terlipressin and octreotide in prevention of early variceal rebleed. The aim of this study was to compare the efficacy of terlipressin with octreotide as an adjuvant therapy to endoscopic variceal band ligation in patients with esophageal variceal bleeding.

Methods: This study (a comparative interventional study) was conducted in Medical Unit II, Jinnah hospital Lahore from December 2012 to June 2013 and 150 patients were included in this study. Cirrhotic patients with esophageal variceal bleed were randomized on admission to receive octreotide (group A) or terlipressin (group B) after endoscopic variceal band ligation. The two groups were compared for prevention of early variceal rebleed.”Control of variceal bleed” was the measure of efficacy of terlipressin and octreotide.

Results: One hundred and fifty patients were included in the study. Re-bleeding occurred in 16 patients (21.33 %) in study group A and in 12 patients (16 %) in study group B (p= 0.402).

Conclusion: It is concluded that terlipressin is as effective in prevention of early variceal rebleed after endoscopic band ligation as octreotide, with minor superiority. Therefore both drugs can be used for prevention of early variceal rebleed after band ligation.

Downloads

Published

2018-11-22

How to Cite

1.
ABBAS RAZA, ARIF MAHMOOD SIDDIQUI MKMKS. “Comparison of Octreotide and Terlipressin Efficacy in Prevention of Early Variceal Rebleed after Endoscopic Variceal Band Ligation’’. J Fatima Jinnah Med Univ [Internet]. 2018 Nov. 22 [cited 2024 May 5];8(1). Available from: https://jfjmu.com/index.php/ojs/article/view/128